5-Year Prospective Evaluation of Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Outcomes: MITRAL Trial Final Results.
Mayra E Guerrero, Mackram F Eleid, Dee Dee Wang...
https://pubmed.ncbi.nlm.nih.gov/37758379/Actively Recruiting
Led by Prince of Wales Hospital, Shatin, Hong Kong · Updated on 2026-09-16
10
Participants Needed
1
Research Sites
26 weeks
Total Duration
This research aims to evaluate the use of the SmartWave lithotripsy balloon in treating severe mitral stenosis caused by mitral annular calcification MAC or heavily calcified rheumatic heart disease. Mitral stenosis is a serious heart valve condition that can be difficult to treat when the valve is heavily calcified, limiting the effectiveness of standard procedures like balloon valvuloplasty or surgery. Existing treatments may carry high risks, and the study explores a new device designed specifically to improve valve flexibility and safety during treatment. The study will use the SmartWave lithotripsy balloon, a device originally developed for calcified aortic valves, to break up calcium deposits in the mitral valve. This device works by targeting hard calcium while preserving soft tissue, potentially making balloon valvuloplasty safer and more effective. Participants will undergo this treatment as the main intervention during the trial period, which is focused on assessing the devices application in this specific heart valve condition. Participants will be closely monitored before, during, and after the procedure through heart imaging and other tests to assess valve function and symptoms. The study will measure improvements in mitral valve area and check for any complications during or immediately after the treatment. Follow-up will continue for up to 12 months to track heart function, symptoms, and any adverse events. Overall, the study aims to understand how the device affects valve flexibility, patient symptoms, and heart health over time.
CONDITIONS
Treating Severe Mitral Valve Annular or Valvular Calcification Using Shockwave Balloon SMARTWAVE
D
Daniel Xu, Nursing Officer
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Prince of Wales Hospital, Shatin, Hong Kong
Lead Sponsor
Peijia Medical Technology (Suzhou) Co., Ltd.
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants receive the SmartWave lithotripsy balloon procedure to treat calcified mitral stenosis.
1 procedure visit
Duration - 12 months
Participants are monitored for up to 12 months after treatment to assess valve function, symptoms, and any complications.
Multiple follow-up visits at 1, 3, 6, and 12 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Mayra E Guerrero, Mackram F Eleid, Dee Dee Wang...
https://pubmed.ncbi.nlm.nih.gov/37758379/Marvin H Eng, Pedro Villablanca, Dee Dee Wang...
https://pubmed.ncbi.nlm.nih.gov/31326427/Gennaro Giustino, Jonathan X Fang, Pedro A Villablanca...
https://pubmed.ncbi.nlm.nih.gov/38127026/Gregg W Stone, David H Adams, William T Abraham...
https://pubmed.ncbi.nlm.nih.gov/26184623/Dean J Kereiakes, Jonathan M Hill, Richard A Shlofmitz...
https://pubmed.ncbi.nlm.nih.gov/37676225/Francesco Maisano, Maurizio Taramasso
https://pubmed.ncbi.nlm.nih.gov/30476035/Mayra Guerrero, Dee Dee Wang, Amit Pursnani...
https://pubmed.ncbi.nlm.nih.gov/32417332/G T Wilkins, A E Weyman, V M Abascal...
https://pubmed.ncbi.nlm.nih.gov/3190958/Alok Sharma, Rosemary Kelly, Mackenzie Mbai...
https://pubmed.ncbi.nlm.nih.gov/32674681/Ziad A Ali, Dean Kereiakes, Jonathan Hill...
https://pubmed.ncbi.nlm.nih.gov/37029020/Prince of Wales Hospital, Shatin, Hong Kong
Lead Sponsor
Peijia Medical Technology (Suzhou) Co., Ltd.
Collaborating Sponsor